Bobcat339 for TET-Linked DNA Methylation Studies
2026-08-14
Bobcat339 is a cytosine structure-based TET enzyme inhibitor for separating TET-dependent DNA demethylation from UHRF1-associated 5-mC and enhancer effects. This practical workflow combines dose-response testing with methylation, enhancer, transcriptional, and osteogenic readouts to support mechanism-focused epigenetics research.
PF-573228: FAK Inhibitor Workflow for Mechanobiology
2026-08-13
PF-573228 connects focal-adhesion signaling with substrate mechanics, cancer-cell behavior, and endothelial phenotypes in one experimentally tractable workflow. Use it as a timed pathway perturbation tool to distinguish stiffness-driven differentiation from downstream effects on migration, survival, and angiogenesis.
Amyloid Beta-peptide (25-35): Assay Logic
2026-08-13
Amyloid Beta-peptide (25-35) is a powerful acute model for separating neuronal injury from inflammatory signaling in Alzheimer’s disease research. This guide connects peptide handling and endpoint selection with the FLOT1–FOSL2–EphA2 findings to improve mechanistic assay design.
Nintedanib (BIBF 1120): Mechanism and Research Use
2026-08-12
Nintedanib, also called BIBF 1120, is an orally active triple angiokinase inhibitor of VEGFR, FGFR, and PDGFR signaling. Its nanomolar kinase-inhibition profile supports antiangiogenic, antifibrotic, and oncology research, while ATRX-deficient glioma findings provide a genotype-aware rationale for studying receptor tyrosine kinase inhibitors.
Shufeng Xingbi Therapy in Allergic Rhinitis Rats
2026-08-12
This preprint evaluates Shufeng Xingbi Therapy in an ovalbumin-induced rat model of allergic rhinitis using behavioral, histological, immunological, gene-expression, and gut-microbiome measurements. The findings link symptom improvement with reduced IgE/IL-4-associated inflammation, altered Th1/Th2-related signaling, increased serum short-chain fatty acids, and shifts in fecal bacterial composition, while also highlighting important limits on causal and clinical interpretation.
Phosbind Biotin for Phosphorylation Analysis
2026-08-11
Phosbind Biotin enables sequence-independent Western Blot detection of phosphorylated proteins when a suitable phospho-specific antibody is unavailable or too narrow. This practical guide connects dinuclear metal complex phosphate binding with drought-response research, experimental design, workflow optimization, and troubleshooting.
Vacuolin-1: From Fusion Blockade to Translation
2026-08-10
Lysosomal exocytosis is emerging as an active driver of tissue pathology rather than a passive consequence of storage. This thought-leadership guide explains how Vacuolin-1 can help translational researchers test the causal role of lysosome–plasma membrane fusion in membrane repair, calcium signaling, lysosomal β-hexosaminidase release, and MPS IVA disease models.
Praeruptorin A Workflows for Inflammation Research
2026-08-09
Build mechanism-led assays around Praeruptorin A, an angular pyranocoumarin compound for studying inflammation, ferroptosis, intestinal barrier repair, cardiac injury, and tumor-cell invasion. Practical dose planning, controls, and troubleshooting help distinguish pathway modulation from solvent effects or nonspecific cytotoxicity.
Acquired CDK7 Inhibitor Resistance in Cancer
2026-08-08
The reference study identifies a CDK7 Asp97Asn mutation that emerges during Samuraciclib selection and selectively reduces sensitivity to non-covalent CDK7 inhibitors. Structural, biochemical, and genetic analyses show that this conserved-residue mechanism may also shape resistance to CDK12 and CDK4 inhibitors, while covalent CDK7 inhibitors retain activity against the CDK7-D97N mutant.
3D Spheroid Assay for Glioblastoma Stemness
2026-08-07
This 2026 Stem Cell Research protocol presents a streamlined 96-well 3D-tumor spheroid assay for functionally assessing stem-like behavior in human glioma cell lines. Its reduced handling burden and shorter workflow may support reproducible stemness comparisons and exploratory therapeutic screening, while spheroid formation remains a surrogate phenotype that requires orthogonal validation.
ROS-Degradable Lipid Nanoparticles Enable Tumor-Selective mR
2026-08-07
Cai et al. introduce a combinatorial library of ROS-degradable lipid nanoparticles that preferentially deliver mRNA to tumor cells by exploiting elevated intracellular ROS. This innovation enables targeted gene expression and demonstrates effective inhibition of mutant RAS signaling, offering a promising strategy for cancer-selective mRNA therapeutics.
Angiotensin 1/2 (2-7): Precision Peptide for Advanced RAS Re
2026-08-06
Angiotensin 1/2 (2-7) unlocks new experimental frontiers in renin-angiotensin signaling, blood pressure regulation, and viral pathogenesis research. With unmatched purity, solubility, and cross-domain relevance, this APExBIO peptide empowers researchers to design robust, reproducible workflows.
Wnt-EGFR Pathways Regulate DNA Damage Response in Drosophila
2026-08-06
This study uncovers how canonical Wnt signaling, via EGFR activation, modulates the DNA damage response and apoptosis in the Drosophila wing imaginal disc. The mechanistic insights have important implications for understanding tissue-specific resistance to DNA damage, with potential relevance for cancer research and chemotherapy resistance.
Mdivi-1: Selective DRP1 Inhibition for Advanced Mitochondria
2026-08-05
Explore how Mdivi-1, a selective DRP1 inhibitor, enables precise manipulation of mitochondrial fission and stress signaling. This article delivers unique insights into the intersection of extracellular matrix remodeling, mitochondrial dynamics, and apoptosis assay design.
EZ Cap™ Cre mRNA (m1Ψ): Optimizing Gene Editing Workflows
2026-08-05
EZ Cap™ Cre mRNA (m1Ψ) transforms gene editing with its robust stability, low immunogenicity, and enhanced translation efficiency. This guide distills advanced protocol strategies, comparative advantages, and troubleshooting insights, empowering researchers to maximize experimental success in both in vitro and in vivo applications.
466 records 9/32 page Previous Next First page 上5页 678910 下5页 Last page